Feb 012016
 

cc-logo[Cable Green, Link (CC-BY)] Creative Commons (CC) believes publicly funded education, research and data resources should be shared in the global commons. The public should have access to what it paid for, and should not be required to pay twice (or more) to access, use, and remix publicly funded resources.

This is why we are pleased to announce that the U.S. Department of Labor (DOL) has adopted a department-wide Creative Commons Attribution (CC BY) license requirement on intellectual property developed under a competitive Federal award process. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Jan 122016
 
Photo by C.E. Kent (CC-BY)

C.E. Kent (CC-BY)

Jahan ‘Harry’ Taubman-Rezakhanlou for Intellectual Property Watch
Link (CC-BY-NC-SA)

More than 50 members of the United States Congress today sent a letter urging the US Department of Health and Human Services (HHS) and National Institutes of Health (NIH) to exercise their legal authority to require medical patents that have emerged from government-funded medical research projects to be licensed on reasonable and affordable terms for public use. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Nov 092015
 

cc summit[Originally posted on the Communia Blog, Link] The Creative Commons Summit, a bi-annual meeting of members of the CC network and friends of the Commons, took place in mid-October in Seoul, South Korea. One of the event’s tracks was devoted to copyright reform advocacy. The track was organised by member organisations of Communia, including Creative Commons.

In 2013, during the previous CC Summit, Creative Commons adopted a position on copyright reform. CC re-emphasized that even though the licenses are an essential mechanism to share creativity within the existing bounds of the law, it is now more important than ever to engage in a review and modernisation of copyright law itself. This commitment was confirmed during this year event. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Oct 292015
 

baten-bianchi-moserAuthors: Joerg Baten, Nicola Bianchi, and Petra Moser

Abstract: This paper investigates whether compulsory licensing – which allows governments to license patents without the consent of patent-owners – discourages invention. Our analysis exploits new historical data on German patents to examine the effects of compulsory licensing under the US Trading-with-the-Enemy Act on invention in Germany. We find that compulsory licensing was associated with a 28 percent increase in invention. Historical evidence indicates that, as a result of war-related demands, fields with licensing were negatively selected, so OLS estimates may underestimate the positive effects of compulsory licensing on future inventions. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Oct 012015
 

chile flagChile is about to become the first country to successfully kill creative commons and other open licensing for audiovisual works with a copyright bill that has been already approved in the House of Representatives  in an unprecedented fast speed. It is now in the Senate. This dream bill for collective societies of rightholders is the Bill for Copyright for Audiovisual Authors.

Here is a link to the bill and the legislative discussions.  Here is how it works against open licensing: Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Aug 132015
 

rcp-lcaAuthors: Rodrigo Cetina Presuel and Loreto Corredoira y Alfonso

Abstract: In 2015, Spain’s new copyright law entered into effect including many new provisions including one that requires Universities to pay Collecting Societies for using manuals and textbooks made available online in virtual campuses. This license cannot be waived and means that Universities have to pay even for works released under free licenses, such as Creative Commons, and for works already in the public domain. This weakens the protection offered by limits such as the one in favor of educational uses (art. 32 of the Spanish copyright act) and also reduces the public domain as it establishes unalienable licenses for content no longer in copyright. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Aug 102015
 
(CC BY) Matt Wade

(CC BY) Matt Wade

Creative Commons USA and over 100 other groups have sent a letter to President Obama urging a policy to ensure that “educational materials created with federal funds… are made available to the public as Open Educational Resources to freely use, share, and build upon” through the use of open licenses. The letter further notes that “the global standard for public copyright licensing for copyrighted content is Creative Commons. Existing U.S. Government grant programs including the TAACCCT and First in the World Programs mentioned above, use the Creative Commons Attribution License (CC-BY). Releasing materials under a standard license, such as CC-BY, allows for increased reuse and compatibility between materials produced by different institutions, including private charitable foundations and other national governments.” Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
May 242015
 

creative commons logo[Timothy Vollmer, Creative Commons, Link, (CC-BY)] Today Creative Commons and 22 other organizations published a letter urging the publishing giant Elsevier to alter its newly revised policy regarding the sharing and hosting of academic articles so that it better supports access to scholarly research.

Elsevier’s new policy, announced 30 April 2015, is detrimental to article authors as well as those seeking access to these research papers. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
May 132015
 

Sen. SandersDear Secretary McDonald:

I am writing to urge you to use your authority as Secretary of Veterans Affairs to break the patents on Hepatitis C medications for the treatment of veterans suffering with the disease.

Last December, as Chairman of the Senate Committee on Veterans’ Affairs, I held a hearing about the high price of Hepatitis C drugs and the impact of those high prices on access to treatment for veterans. At the time, I raised concerns that the price of these new Hepatitis C drugs, specifically Sovaldi, which is manufactured by Gilead Sciences, even when discounted, would preclude veterans from accessing these life-changing drugs. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Mar 122015
 

cc open edu icon[Cross posted from the CCUSA blog, Link (CC-BY)] In all my time with Creative Commons, I’ve come to see that support comes from people across a wide spectrum of creators. For some, the Creative Commons licenses and their related icons provide the vocabulary and the solidarity around the sharing that they would engage in over the Internet even if the licenses did not exist. For others, the licenses are needed to free users from copyright constraints that would otherwise inhibit or prohibit uses that the creator wants to promote. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Feb 262015
 

hcv report cover[Yale Global Health Partnership press release] Just last week, worldwide leaders came together in Geneva, Switzerland at the World Health Organization to begin to develop a five-year strategy to combat Hepatitis C. The disease, which affects 185 million people worldwide – five times as many people as HIV, predominantly in low-and middle-income countries – has been called a silent epidemic. Now, a new report by Yale’s Global Health Partnership (GHJP), the Treatment Action Group (TAG) and the Initiative for Medicines, Access and Knowledge (I-MAK) warns that global efforts to extend treatment to millions is in peril unless key obstacles to access are confronted immediately…  strategies used with other diseases, particularly HIV/AIDS, to extend treatments to millions who need it has largely depended on getting less expensive, generic versions of these drugs on the market, by pressuring companies to allow other manufacturers to produce their drugs.

Yale GHJP Press Release | Full Report

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Feb 242015
 

medicines patent poolCompany joins five other MPP patent holders in efforts to improve HIV paediatric care

[Reposted from the Medicines Patent Pool, Link, (CC-BY-NC-ND)]  The Medicines Patent Pool (MPP) announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with HIV four weeks of age and older. With the new licence, generic manufacturers and other companies based anywhere in the world can develop, manufacture and sell low cost, paediatric versions of raltegravir in countries with the highest burden of disease, where 98 percent of children with HIV in the developing world live. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly